Scot C. Remick, M.D., who will become director of the Mary Babb Randolph Cancer Center at West Virginia University in July, was welcomed Thursday with a $50 million-plus commitment to the cancer centers future.
WVU and WVU Hospitals are 100 percent behind Dr. Remick, and we are backing that support with a massive investment in the Cancer Center,said WVU President David C. Hardesty, Jr.WVU Hospitals is building a $23 million expansion to the center. The School of Medicine and the hospital are jointly funding a $25 million plan to expand our clinical and research faculty. And private donors will raise millions more to assure that West Virginians have access to the very best in cancer care.
Remick, a renowned cancer physician and researcher, comes to WVU from the Case Comprehensive Cancer Center, Cleveland, where he served as the associate director for clinical research.
On Thursday, he met with Cancer Center faculty and staff and delivered the centers annual DeLynn lecture. One of the things he talked about was the Cancer Centers future.
Among the most attractive aspects of this position is the extraordinary energy and commitment of all our partners in the Mary Babb Randolph Cancer Centerincluding the clinical and research faculty, staff, institutional leadership, and most importantly the residents of Morgantown and countless friends and benefactors throughout the State of West Virginia. I am convinced the center is poised for great things,Remick said.
The Cancer Center is in the midst of an unprecedented expansion. The $23 million facility improvement plan is already under construction. The 60,000-square foot project will expand the Cancer Center’s patient care areas. The result will be a more spacious facility, featuring a clinic double the size of the existing one, with additional exam rooms, larger, more comfortable waiting areas, easier access to hospital services, a patient library, and more efficient patient registration.
By adding faculty members who focus on cancer, Remick will be able to move forward with the Universitys goal of interdisciplinary cancer research, and be in a better position to win competitive research funding.
At Case, Remick has been among the physician leaders of a world-class comprehensive cancer center. He has established relationships with pharmaceutical industry research-funding groups, and has participated in numerous clinical trials. He has been an active participant in national and international cancer research efforts.
Remick has been principal investigator or co-investigator on tens of millions of dollars in externally funded cancer and AIDS research at Case. He is a graduate of New York Medical College, with residency training at Johns Hopkins and fellowship training at the University of Wisconsin Clinical Cancer Center.
The selection of such an accomplished researcher is encouraging to scientists at WVU , said Dan Flynn, Ph.D., the Cancer Centers deputy director.”Scot Remick brings to the Cancer Center a wealth of experience in clinical trials. His expertise and knowledge will help the center integrate research with clinical care, expand our services and offer cutting edge treatment options for our patient populations.”
The Mary Babb Randolph Cancer Center is West Virginias premier cancer facility, with a national reputation of excellence in cancer treatment, prevention and research. T he cancer center serves thousands of people from around the state and region, and offers patients access to both well-established treatments and the latest clinical trials of new medications and other cancer treatments. Patients have access to WVU s advanced imaging center for precise diagnosis.